granted
on 16 Sep 2024
Last Applicant/ Owned by
300 Fifth Avenue, Suite 6040
Waltham
MA
02451
Serial Number
90635722 filed on 09th Apr 2021
Registration Number
N/A
Correspondent Address
Monica Riva Talley
Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
10th Floor
WASHINGTON, DC 20005
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with cancer, and RNA expression levels; pharmaceutical research services; providing an on-line searchable database in the field of life science for scientific research purposes; providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, Read More
Medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with cancer, and RNA expression levels; pharmaceutical research services; providing an on-line searchable database in the field of life science for scientific research purposes; providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, and genetics; scientific and medical laboratory services; providing use of non-downloadable cloud-based computer software for measuring, testing, analyzing, and processing biological samples
N/A
N/A
Medical test kits, comprising test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene mutations associated with cancers and RNA expression levels
N/A
N/A
Downloadable computer software for use in analyzing, managing, visualizing and storing data; downloadable computer software for measuring, testing, analyzing, and processing biological samples
N/A
N/A
Chemical preparations for laboratory and diagnostic use in the medical, veterinary or pharmaceutical field, namely, chemical preparations for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, drug responses, and monitoring of tumors; diagnostic preparations for medical, veterinary or pharmaceutical use for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, drug responses, monitoring of tumors, and analysis of DNA or RNA; kits comprising chemical preparations and diagnostic preparations for medical, veterinary or pharmaceutical use for use in relation to the detection, treatment or monitoring of cancer, inherited disease, genetic predispositions, drug responses, monitoring of tumors and analysis of DNA or RNA; kits comprising primarily of assays, reagents, enzymes and/or nucleotides for medical diagnostic use
N/A
N/A
Chemical preparations for use in analyzing DNA or RNA for scientific purposes; kits comprising chemical preparations for use in analyzing DNA or RNA for scientific purposes
N/A
N/A
No 90635722
No Service Mark
No 5488.0260000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Sep 2024 | SOU EXTENSION 5 FILED |
16th Sep 2024 | SOU EXTENSION 5 GRANTED |
16th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
16th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
14th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Mar 2024 | SOU EXTENSION 4 FILED |
13th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
13th Mar 2024 | SOU EXTENSION 4 GRANTED |
16th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Sep 2023 | SOU EXTENSION 3 GRANTED |